LORINDEN A

This brand name is authorized in Lithuania, Poland

Active ingredients

The drug LORINDEN A contains a combination of these active pharmaceutical ingredients (APIs):

1 Flumetasone UNII LR3CD8SX89 - FLUMETHASONE

Read about Flumetasone

2 Salicylic acid UNII O414PZ4LPZ - SALICYLIC ACID

Salicylic acid has bacteriostatic and fungicidal actions, but it is its keratolytic properties which are important for this medicinal product. When applied externally it produces slow and painless destruction of the epithelium. Read about Salicylic acid

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D07XB01	Flumetasone	D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07X Corticosteroids, other combinations → D07XB Corticosteroids, moderately potent, other combinations
Discover more medicines within D07XB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010797
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100039743, 100125767, 100295920, 100344771, 100362450, 100365483, 100373896, 100400140, 100407603, 100408726, 100423476, 100438101, 100455134